Upgrade to SI Premium - Free Trial

Rocket Pharmaceuticals (RCKT) PT Raised to $11 at Leerink Partners

March 27, 2026 3:02 PM
Leerink Partners analyst Mani Foroohar raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $11.00 (from $9.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change